Amy N. Schilling
- Pharmacology top 2%
- Molecular Medicine top 1%
- Epidemiology top 10%
- Applied Microbiology and Biotechnology top 1%
- Molecular Biology
- Co-authors
- Vincent H. TamElizabeth A. CoyleMichael NikolaouKeith PooleDavid MelnickRussell E. LewisShádi NeshatNathan P. Wiederhold
- Topics
- Antibiotic Resistance in Bacteria (13 papers)Antibiotics Pharmacokinetics and Efficacy (12 papers)Pneumonia and Respiratory Infections (5 papers)
- Journals
- Antimicrobial Agents and ChemotherapyCritical Care MedicineJournal of Antimicrobial Chemotherapy
- Partner nations
- United StatesCanadaSingapore
In The Last Decade
Amy N. Schilling
18 papers receiving 886 citations
Peers
Comparison fields: 5 of 98
- Pharmacology 514
- Molecular Medicine 489
- Epidemiology 261
- Applied Microbiology and Biotechnology 189
- Molecular Biology 141
Countries citing papers authored by Amy N. Schilling
This map shows the geographic impact of Amy N. Schilling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy N. Schilling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy N. Schilling more than expected).
Fields of papers citing papers by Amy N. Schilling
This network shows the impact of papers produced by Amy N. Schilling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy N. Schilling. The network helps show where Amy N. Schilling may publish in the future.
Co-authorship network of co-authors of Amy N. Schilling
This figure shows the co-authorship network connecting the top 25 collaborators of Amy N. Schilling. A scholar is included among the top collaborators of Amy N. Schilling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy N. Schilling. Amy N. Schilling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 12 | |
| 4 | 11 | |
| 5 | 31 | |
| 6 | 89 | |
| 7 | 16 | |
| 8 | 15 | |
| 9 | 19 | |
| 10 | 25 | |
| 11 | 47 | |
| 12 | 39 | |
| 13 | 98 | |
| 14 | 102 | |
| 15 | 21 | |
| 16 | 169 | |
| 17 | 169 | |
| 18 | 28 | |
| 19 | A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878). | 12 |
About Amy N. Schilling
Amy N. Schilling is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 19 papers that have together received 913 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (13 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Pneumonia and Respiratory Infections (5 papers). The work is most often cited by research in Molecular Medicine (489 citations), Applied Microbiology and Biotechnology (189 citations) and Pharmacology (514 citations). Amy N. Schilling has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Vincent H. Tam, Elizabeth A. Coyle, Michael Nikolaou, Keith Poole, David Melnick, Russell E. Lewis, Shádi Neshat, Nathan P. Wiederhold, Andrea Lay‐Hoon Kwa and Rebecca Corey. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Critical Care Medicine and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.